Navigation Links
Giant Eagle Pharmacy Free Antibiotics Program Surpasses $3 Million in Free Prescriptions
Date:2/12/2010

PITTSBURGH, Feb. 12 /PRNewswire/ -- Pittsburgh-based food and fuel retailer Giant Eagle, Inc. launched its free antibiotics program in September of 2009, and is pleased to announce that the program has resulted in more than $3 million in free prescriptions for customers in the company's four-state operating area.

To date, more than 590,000 prescriptions for free antibiotics have been filled by the Giant Eagle Pharmacy, treating common infections that range from strep throat, ear infections and conjunctivitis to bladder infections, pneumonia, acne, urinary tract and skin infections.

"Giant Eagle launched our free antibiotics program as part of our commitment to improving the health and wellness of our communities," said Giant Eagle Vice President of Pharmacy, Randy Heiser.  "We are very pleased to see such great customer acceptance and confidence in Giant Eagle Pharmacy to deliver these vital prescriptions for children and adults."

In Western Pennsylvania stores, Heiser said that approximately 280,000 prescriptions were filled amounting to nearly $1.4 million.  Across all of its pharmacies, the free antibiotics program has resulted in the addition of more than 135,000 new pharmacy customers to Giant Eagle and more than 1.8 million new scripts from current pharmacy customers.

The program is an extension of Giant Eagle's ongoing price reductions efforts and builds on the company's successful $4 generic prescription medication program that has delivered an additional $30 million in annual customer savings.

"With so many families experiencing some level of economic hardship, medical professionals have worried that prescriptions go unfilled because patients simply can't afford them," said Heiser.  "While people are still navigating challenging times, we've seen a very positive response to our free antibiotics offer which clearly indicates it is filling a real need."

The antibiotics available under the program with a valid prescription are Amoxicillin, Ampicillin, Cephalexin, Ciprofloxacin, Doxycycline Hyclate, Erythromycin, Gentamicin, Penicillin, Sulfamethoxazole/Trimethoprim and Tetracycline.

About Giant Eagle

Giant Eagle Inc., ranked 40 on Forbes magazine's largest private corporations list and recipient of Grocery Headquarters' 2007 Retailer of the Year Award and the EPA's ENERGY STAR Retail Partner of the Year Award, is one of the nation's largest food retailers and food distributors with approximately $8.2 billion in annual sales.  Founded in 1931, Giant Eagle, Inc. has grown to be the number one supermarket retailer in the region with 164 corporate and 58 independently owned and operated supermarkets in addition to 154 fuel and convenience stores throughout western Pennsylvania, Ohio, north central West Virginia and Maryland.  

SOURCE Giant Eagle, Inc.


'/>"/>
SOURCE Giant Eagle, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Intellicig Clinches Exclusive Deal with Retail Distribution-Giant to Distribute Their Industry Leading Electronic Cigarettes
2. All-Time Giant Great Receives Humanitarian of the Year Award
3. November Is Report Card Month: Tutorgiant.com Suggests That Online Tutoring May Be The Solution To Bad Report Cards
4. Web Giants Urge FDA to Update Ad Guidelines
5. 1 small step for neurons, 1 giant leap for nerve cell repair
6. Texas Doctor Files Case Pro Se in U.S. Supreme Court Against Insurance Giant on Integrity and Unethical Practices
7. Cancer Advocacy Organization Confronts the Source of rBGH, Demands Pharmaceutical Giant Eli Lilly Stop Milking Cancer
8. PSE&G Childrens Specialized Hospital and New York Giants Team Up to Offer Text to Donate Campaign
9. New York Giants to Host American Red Cross Blood Drive
10. Nevada Burning Man Festival Sees Giant Aerial Marijuana Bud Banner That Protests Hydroponics Hijacking
11. Labor Day Beach Visitors Will See Giant Hydroponics Marijuana Bud Banner Flying Over Los Angeles & San Diego
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Stephanie Hebert Insurance ... beginning of a new charity campaign. As part of their ongoing community involvement ... In the belief that children deserve a voice, and in the spirit of ...
(Date:2/8/2016)... ... February 08, 2016 , ... Tingley ... into Canada to provide its range of unique and advantaged protective solutions ... City that will provide bilingual customer service and marketing support. A new distribution ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... announced today that nominations will be accepted February 8, 2016 through May ... , Awards include the Information Security Executive® of the Year, which recognizes ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort with substantially ... to make a change in public health,” states Carole Baggerly, Director of GrassrootsHealth, ...
(Date:2/8/2016)... ... February 08, 2016 , ... The schedule is now online ... AutismOne 2016 Conference, which is being held May 25-29 at the Loews Chicago O’Hare ... helpful interventions and causes of chronic illness in children. , Very recent articles have ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... 2016  The Parenteral Drug Association, Inc. (PDA), ... manufacturing sterile drug products, today announced the publication ... – With link to Comparison Spreadsheet. The ... U.S. FDA, the EU, the Pharmaceutical Inspection Convention/Scheme ... --> --> PDA,s Global Sterile ...
(Date:2/8/2016)... Feb.8, 2016 Cardiovascular Surgery Devices - ... GlobalData,s Medical Devices sector report, "Cardiovascular Surgery Devices ... overview of Cardiovascular Surgery Devices currently in pipeline ... The report provides comprehensive information on the ... at various stages of development. The report reviews ...
(Date:2/8/2016)... FAIRFIELD, N.J. , Feb. 8, 2016  Otsuka ... today announced that they have entered into a licensing ... OPA-15406 in the U.S. and Puerto Rico ... is a topical, non-steroidal phosphodiesterase IV (PDE-4) inhibitor, a ... --> --> In a Phase II ...
Breaking Medicine Technology: